Moteur de recherche d’entreprises européennes
Financement de l’UE (5 999 998 €) : Évaluation des risques liés aux rayonnements pour les effets nocifs de l’exposition médicale lors de la prise en charge des patients atteints d’un lymphome ou d’ … Hor31/05/2020 Programme de recherche et d'innovation de l'UE « Horizon »
Texte
Évaluation des risques liés aux rayonnements pour les effets nocifs de l’exposition médicale lors de la prise en charge des patients atteints d’un lymphome ou d’une tumeur cérébrale
Reinforced risk appraisal of medical exposure is needed due to an extensive use of ionising radiation for diagnosis and therapy. The main objective of the 4-year SINFONIA project is to develop novel methodologies and tools that will provide a comprehensive a risk appraisal for detrimental effects of radiation exposure on patients, workers, carers and comforters, the public and the environment during the management of patients suspected or diagnosed with lymphoma and brain tumours. The scientific work will (1) develop novel AI-powered personalised dosimetry and risk appraisal methods and tools to estimate the radiation burden on patients undergoing state-of-the-art radiological, nuclear medicine and radiation therapy procedures, (2) reinforce risk appraisal for exposed staff, comforters, the public and the environment during nuclear medicine and proton therapy procedures, (3) determine the degree of patient variability in radiation sensitivity for the risk of developing secondary malignancies and (4) design and develop data management techniques for managing data from imaging and non-imaging examinations and radiation therapy sessions. A data repository will be developed for storing data as well as for the deployment of AI algorithms on an online platform. SINFONIA research outcomes for the two clinical examples, lymphoma and brain tumours, will be also applicable to other diseases. AI-powered personalised dosimetry tools will provide advanced knowledge on parameters affecting radiation detriment. This will help balancing risks and benefits of ionising radiation procedures and developing dose optimisation strategies. Additionally, radiation biology studies will identify individuals with increased susceptibility of developing cancer from ionising radiation exposure. SINFONIA also will organise high-level multidisciplinary training in the field of radiation dosimetry, risk appraisal and radiation protection and develop recommendations on radiological protection.
| Eibir Gemeinnutzige GmbH ZUR Forderung DER Erforschung DER Biomedizinischen Bildgebung | 576 875 € |
| Fundacion Publica Gallega Centro Tecnologico de Supercomputacion de Galicia | 387 408 € |
| Galaria Empresa Publica de Servizos Sanitarios SA | 0,00 € |
| Kommunalforbundet Skandionkliniken | 500 000 € |
| Narodowe Centrum Badan Jadrowych | 170 375 € |
| OTTO-VON-GUERICKE-UNIVERSITAET MAGDEBURG | 353 275 € |
| Panepistimio Kritis | 618 625 € |
| Qaelum N.V. | 290 000 € |
| Servizo Galego de Saude | 296 533 € |
| Stockholms Universitet | 718 500 € |
| Studiecentrum Voor Kernenergie / Centre d'Etude de l'Energie Nucleaire | 632 828 € |
| Swietokrzyskie Centrum Onkologii Samodzielny Publiczny Zaklad Opieki Zdrowotnej w Kielach | 72 500 € |
| UNIVERSITE DE GENEVE | 549 330 € |
| Universiteit Gent | 591 250 € |
| Uniwersytet Jana Kochanowskiego w Kielcach | 242 500 € |
https://cordis.europa.eu/project/id/945196
Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel.
